FIGURE

Figure 9

ID

ZDB-FIG-221214-136

Publication

Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation

Other Figures

All Figure Page

Back to All Figure Page

Figure 9

Effect of MitoTEMPO on doxorubicin-induced stimulation of ctsk cells. The ctsk reporter zebrafish transgenic line (Tg[ctsk:DsRed]) at 25 dpf was exposed to MitoTEMPO (MT, 20 µM) alone or together with doxorubicin (DOX, 17.2 µM) for 96 h. Quantification of fluorescence intensity between the treatment groups (A) and the ctsk signal in the head area of fish from the different treatment groups (B). One-way ANOVA, Tukey’s multiple comparisons test, ****—p ≤ 0.0001.

Expression Data

Gene:	DsRed
Fish:	mh201Tg
Conditions:	chemical treatment by environment: doxorubicin chemical treatment by environment: doxorubicin chemical treatment by environment: antioxidant
Anatomical Term:	head osteoclast
Stage:	Days 21-29

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	mh201Tg
Conditions:	chemical treatment by environment: doxorubicin chemical treatment by environment: doxorubicin chemical treatment by environment: doxorubicin chemical treatment by environment: antioxidant chemical treatment by environment: resveratrol
Observed In:	forward locomotion head osteoclast osteoclast differentiation
Stage:	Days 21-29

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.